Genentech

Close-up of human eye
Biotech

BioCryst scraps eye drug to focus on rare diseases

BioCryst announced it has ended development of avoralstat, which was being studied to treat diabetic macular edema.
Will Maddox May 6, 2026 10:40am
Roche

Roche unpacks death imbalance in multiple sclerosis ph. 3 trials

Apr 21, 2026 7:15pm
vault

Roche takes ‘leap of faith’ with bet on C4T’s protein degraders

Apr 9, 2026 7:00am
dominoes stop stall halt end red

Genentech drug fails rare disease study, raising obesity questions

Mar 20, 2026 2:11pm
Stop sign and red lights at traffic intersection

Genentech shreds RIPK1 inhibitor after ph. 2 failure

Mar 19, 2026 2:48pm
Completing steps towards success checkmark on cubes symbolizing progress

Roche reports pivotal MS win, but deaths add to safety questions

Mar 2, 2026 6:00am